CYNO Stock News 21.55 05/13/2014 12:19:02 Cynosure Inc (CYNO

New Post Public Reply Private Reply Replies (0) Message Board

May 13, 2014 at 1:19 PM

Cynosure Inc (CYNO) 21.55 $CYNO

Zacks Rank #5 Additions for Thursday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu May 08, 8:30AM CDT
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List for Thursday

Nasdaq stocks posting largest percentage decreases
AP - Wed May 07, 5:02PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at the close of trading:

Cynosure Has Returned 23.1% Since SmarTrend Recommendation (CYNO)
Comtex SmarTrend(R) - Tue May 06, 5:15PM CDT
SmarTrend identified a Downtrend for Cynosure (NASDAQ:CYNO) on March 20th, 2014 at $29.39. In approximately 2 months, Cynosure has returned 23.06% as of today's recent price of $22.61.

Why Cynosure (CYNO) Stock Is Down Today
at The Street - Tue May 06, 12:37PM CDT
Cynosure (CYNO) shares are down after missing analysts earnings and revenue guidance in its first quarter earnings results.

Cynosure Reports First-Quarter 2014 Financial Results
PR Newswire - Tue May 06, 7:00AM CDT
Cynosure, Inc. (Nasdaq: CYNO), which develops and markets laser- and light-based aesthetic treatment systems for high-volume applications, today reported financial results for the three months ended March 31, 2014. First-quarter 2014 financial results incorporate the acquisition of Palomar Medical Technologies, which was completed in June 2013.

Downtrend Call Working As Cynosure Stock Falls 15.4% (CYNO)
Comtex SmarTrend(R) - Tue Apr 29, 11:11AM CDT
SmarTrend identified a Downtrend for Cynosure (NASDAQ:CYNO) on March 20th, 2014 at $29.39. In approximately 1 month, Cynosure has returned 15.36% as of today's recent price of $24.87.

Shares of CYNO Down 14.5% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Tue Apr 22, 10:02AM CDT
SmarTrend identified a Downtrend for Cynosure (NASDAQ:CYNO) on March 20th, 2014 at $29.39. In approximately 1 month, Cynosure has returned 14.48% as of today's recent price of $25.13.

Cynosure to Host First-Quarter 2014 Financial Results Conference Call on May 6
PR Newswire - Tue Apr 22, 7:30AM CDT
Cynosure, Inc. (Nasdaq: CYNO), which develops and markets laser- and light-based aesthetic treatment systems for high-volume applications, today announced that the company will release its first-quarter 2014 financial results before the market opens on Tuesday, May 6 and host a conference call for investors and analysts that day at 9:00 a.m. ET.

Cynosure Shares Down 11.1% Since SmarTrend's Sell Call (CYNO)
Comtex SmarTrend(R) - Fri Apr 11, 10:17AM CDT
SmarTrend identified a Downtrend for Cynosure (NASDAQ:CYNO) on March 20th, 2014 at $29.39. In approximately 3 weeks, Cynosure has returned 11.08% as of today's recent price of $26.13.

AngioDynamics Q3 Earnings Flat but Beat Ests - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Apr 11, 8:28AM CDT
ANGO lowered its adjusted EPS guidance for fiscal 2014 to a range of 60 to 63 cents from the prior range of 63 to 67 cents.

Delcath Systems (DCTH) Worth Watching: Stock Soars 20.1% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Apr 11, 8:25AM CDT
Delcath Systems was a big mover last session, with shares surging over 20% on the day.

Masimo Reports Encouraging PVI Study Results - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Apr 10, 5:40PM CDT
The results demonstrated that MASI's non-invasive PVI parameter helps clinicians optimize fluid administration for abdominal surgical patients under combined general and epidural anesthesia.

Delcath Systems Shares Tank on Stock Split - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Apr 10, 1:50PM CDT
Delcath has been going through a rough patch after it failed to win approval from U.S. Food and Drug Administration (FDA) for its Melblez liver cancer therapy device.

Financial Results Announcement, Stock Movement, Presentations, and Acquisition - Analyst Notes on Universal Health Services, Tenet, Cynosure, Albany Molecular Research, and Enanta
PR Newswire - Thu Apr 10, 9:49AM CDT
Today, Analysts Review released its analysts' notes regarding Universal Health Services, Inc. (NYSE: UHS), Tenet Healthcare Corp. (NYSE: THC), Cynosure, Inc. (NASDAQ: CYNO), Albany Molecular Research Inc. (NASDAQ: AMRI), and Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register

Cepheid (CPHD) Looks Good: Stock Adds 5.3% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Apr 10, 8:04AM CDT
Cepheid was a big mover last session, as the company saw its shares rise over 5% on the day.

Intuitive Surgical (ISRG) Crumbles: Stock Falls by 6.8% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Apr 10, 7:34AM CDT
Shares of Intuitive Surgical fell nearly 7% on the day. This continues the recent trend of the company, as the stock is now trading within the volatile price range of $422.1 to $540.6 in the past one-month time frame.

Varian Medical Systems Closes Velocity Software Acquisition - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Apr 09, 2:20PM CDT
Post-acquisition, VAR expects its global sales, service and support network to contribute to faster and deeper market penetration for the Velocity product.

Intuitive Surgical Expects Lower Q1 Revs, Shares Dip - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Apr 09, 1:50PM CDT
Per Intuitive Surgical, the deferrals will reduce Systems revenues by roughly $24 million and Instruments and Accessories revenues by $2 million.

Echo Therapeutics Slips to Sell - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Apr 07, 1:50PM CDT
Echo Therapeutics' fourth-quarter reported loss per share more than doubled year over year to $3.9 million or 36 cents.

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Cooper's Heat Pump Campaign Fuels Denver's Community

How Heat Pumps Meet Philanthropy in Denver Alright, let me lay it out for you—a story as much about ingenuity as generosity. Cooper Heating & Cooling, donning their ‘Cooper Green Team’ capes, just wrapped up one heck of a community-driven campaign. They dropped a cool $5,000 into the coffers of We Don't Waste, a Denver nonprofit focused on food recovery. This...

CVRx Faces Legal Storm: Class Action Threat Looms

Cracks in the Foundation: CVRx's Turmoil Let me tell you, it's not every day you see a company drop a bombshell on investors like CVRx did, shaking up the ole portfolio right down to its socks. NASDAQ:CVRX has found itself embroiled in a class action lawsuit courtesy of a knotty mix of legal woes, unplanned revenue slashes, and executive shake-ups. A few short years ago,...

RAI's TrustX Lab Unveils AI Assurance Framework

Pushing the Envelope on AI Control Alright, AI wonks, the Responsible AI Institute just introduced a new sheriff in town. It's called the TrustX Assurance Lab, and it was rolled out during RAISE 2026. We're talking about an independent setup designed to answer whether autonomous AI can stay within its limits. Who's involved? A lot of brainpower from member organizations...

Shukla MD's New Concierge Program Boosts Patient Care

Shifting the Healthcare Paradigm Imagine a healthcare world where doctors actually have the time to listen and engage with you beyond just scribbling notes in haste. That's what's brewing over in Westchester, where Dr. Rachana and Dr. Vaishalee Shukla are putting the old-school patient-doctor relationship front and center with their Hybrid Choice concierge program. Run...

CaliberMRI Revolutionizes Preclinical MRI with New Phantom

CaliberMRI: Pioneers Shaping the Future of MRI Hot off the press, folks—CaliberMRI, known for setting the bar high in MRI standardization, has unleashed a new beast on the scene. Enter Model 340, a preclinical quantitative MRI phantom, ready to knock the socks off high-field systems. They’re talking 4.7T, 7T, and a jaw-dropping 9.4T compatibility here. This isn't just...

Capital Properties Faces Leadership Challenge Amid Health News

Leadership Takes an Unexpected Turn at Capital Properties When the helm of a ship faces turbulence, everyone's eyes turn to the captain. In the case of Capital Properties, Inc., their captain, Chairman, CEO and President Robert H. Eder, has hit a personal snag, diagnosed with cancer but determined to steer steady despite the storm brewing within. A Glance at Capital...

Meijer Team Gives Fuels Midwest Nonprofits: $3M Impact

Power to the Team: Meijer Makes Big Moves On any ordinary day, you'd see folks in Grand Rapids, Michigan, bustling about their routines, but today packs a different vibe. Meijer, the retailer that's been around the block a few times, is handing over a serious chunk of change to the tune of $3 million. This ain't just some half-hearted corporate stunt. Nope, this is the...

Graphy's EU-MDR Milestone: A New Era for Dental 3D Printing

TeraHarz Material Certification: A Step Forward The medical device world has its own Everest, and for Graphy Inc., scaling it means navigating the EU's toughened Medical Device Regulation. They’ve done just that for five of their TeraHarz materials, gearing up to snatch those shiny CE-MDR certificates soon. For anyone keeping tabs on the dental market, that’s a big...

Outdoor Learning: Sparking Preschool Curiosity Weekly

Rekindling Curiosity in Nature’s Classroom With autumn’s crisp air rolling into Greenville, families have a golden opportunity to take learning beyond the traditional classroom. Archway Academy sees the beauty of this season as a sprawling classroom, one that doesn't confine young minds and bodies. For those of us focused more on dollars and sense, the financial...

Budget Airlines' Woes Reveal Travel Insurance Pitfalls

A Turbulent Ride for Travelers Man, it seems like the skies aren't so friendly nowadays, especially if you've got your hard-earned dollars wrapped up in a flight with a budget airline like Spirit or JetBlue. Here's the latest scoop: JetBlue's finances are under the microscope, and if you're planning to fly with them, you better become a travel insurance expert pronto. The...